Inner Mongolia Furui Medical Science Co 300049.SZ · CNY

Its shares trade on Shenzhen under the ticker 300049.SZ. It has been listed since 20 January 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.59bn and net income of CN¥154.1m. At that date it held total assets of CN¥3.44bn and shareholders' equity of CN¥1.98bn.

Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of disease diagnosis, drug treatment, and chronic disease management services for liver disease. The company is headquartered in Beijing, Beijing. The company went IPO on 2010-01-20. The firm is mainly engaged in the manufacture and sale of medicines, the research, development and sale of diagnostic equipment, as well as the provision of related services. The Company’s main products include Fufang Biejia Ruangan talbets, Kezhi capsules and instantaneous elastic imaging equipment FibroScan. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

• Guanyi WangChairman of the Board, since 2007CN¥530,000
• Suiyong ZhangVice Chairman of the Board, General Manager, since 2008CN¥485,400
• Mr. Weidong YuVice Chairman of the Board, since 2007
• Fei ShuoDeputy General Manager, Director, since 2007CN¥348,400
• Mr. Yiwei LuDeputy General Manager
• Xinhong WangDeputy General Manager
• Yong YangDeputy General ManagerCN¥400,000
• Xin LinSecretary of the Board, Executive Deputy General Manager, Director, since 2008CN¥570,000
• Zhanbao TieDirectorCN¥120,000
• Jialei WangDirector
• Mr. Yiling ZhangDirector
• Mr. Mingliang ChengIndependent DirectorCN¥50,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.